DK1154988T3 - Mevinolinderivater - Google Patents

Mevinolinderivater

Info

Publication number: DK1154988T3
Authority: DK; Denmark
Prior art keywords: mevinoline; derivatives; mevinoline derivatives
Prior art date: 1999-02-16

Application number

DK00916832T

Other languages

English (en)

Inventor

Josef Gottfried Meingassner

Rolf Baenteli

Wilfried Bauer

Sylvain Cottens

Claus Ehrhardt

Joerg Kallen

Francois Nuninger

Gabriele Weitz-Schmidt

Ulrich Hommel

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-16

Filing date

2000-02-14

Publication date

2004-11-22

1999-02-16 Priority claimed from GB9903546A external-priority patent/GB9903546D0/en

1999-11-25 Priority claimed from GB9927880A external-priority patent/GB9927880D0/en

2000-02-14 Application filed by Novartis Ag filed Critical Novartis Ag

2004-11-22 Application granted granted Critical

2004-11-22 Publication of DK1154988T3 publication Critical patent/DK1154988T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being saturated and containing rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being unsaturated and containing rings other than six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing rings other than six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
- C07D265/08—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D265/10—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen atoms directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
- C07C2602/28—Hydrogenated naphthalenes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Dermatology (AREA)
Diabetes (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Hematology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Oncology (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Psychiatry (AREA)
Ophthalmology & Optometry (AREA)
Communicable Diseases (AREA)
Physical Education & Sports Medicine (AREA)
Transplantation (AREA)

DK00916832T 1999-02-16 2000-02-14 Mevinolinderivater DK1154988T3 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB9903546A GB9903546D0 (en)	1999-02-16	1999-02-16	Organic compounds
GB9927880A GB9927880D0 (en)	1999-11-25	1999-11-25	Organic compounds
PCT/EP2000/001191 WO2000048989A1 (en)	1999-02-16	2000-02-14	Mevinolin derivatives
EP00916832A EP1154988B1 (en)	1999-02-16	2000-02-14	Mevinolin derivatives

Publications (1)

Publication Number	Publication Date
DK1154988T3 true DK1154988T3 (da)	2004-11-22

Family

ID=26315146

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK00916832T DK1154988T3 (da)	1999-02-16	2000-02-14	Mevinolinderivater

Country Status (17)

Country	Link
US (2)	US20020037895A1 (da)
EP (1)	EP1154988B1 (da)
JP (1)	JP4167806B2 (da)
CN (1)	CN1229335C (da)
AR (1)	AR022588A1 (da)
AT (1)	ATE273272T1 (da)
AU (1)	AU763357B2 (da)
BR (1)	BR0008292A (da)
CA (1)	CA2361841C (da)
CO (1)	CO5140104A1 (da)
DE (1)	DE60012888T2 (da)
DK (1)	DK1154988T3 (da)
ES (1)	ES2226802T3 (da)
PE (1)	PE20001495A1 (da)
PT (1)	PT1154988E (da)
SI (1)	SI1154988T1 (da)
WO (1)	WO2000048989A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2758037B2 (ja) *	1989-08-04	1998-05-25	株式会社アマダ	タレットパンチプレスの金型インデックス装置
US6110922A (en)	1998-12-29	2000-08-29	Abbott Laboratories	Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
US6878700B1 (en)	1998-12-29	2005-04-12	Abbott Laboratories	Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
JP2004502681A (ja)	2000-06-29	2004-01-29	アボット・ラボラトリーズ	アリールフェニル複素環スルフィド誘導体および細胞接着を阻止する抗炎症性および免疫抑制性物質としてのその使用
EP1322306A2 (en) *	2000-09-19	2003-07-02	NovImmune S.A.	Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
GB0217152D0 (en) *	2002-07-24	2002-09-04	Novartis Ag	Organic compounds
AU2003282510A1 (en)	2002-10-11	2004-05-04	Bristol-Myers Squibb Company	Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents
EP1682537B1 (en)	2003-11-05	2012-03-28	SARcode Bioscience Inc.	Modulators of cellular adhesion
JP4710612B2 (ja) *	2003-12-26	2011-06-29	日本新薬株式会社	オクタヒドロナフタレン誘導体及び医薬
WO2005123777A2 (en) *	2004-06-09	2005-12-29	Genentech, Inc.	Method of treating granuloma annulare or sarcoid
WO2006115509A2 (en)	2004-06-24	2006-11-02	Novartis Vaccines And Diagnostics Inc.	Small molecule immunopotentiators and assays for their detection
TW200616634A (en)	2004-10-01	2006-06-01	Bristol Myers Squibb Co	Crystalline forms and process for preparing spiro-hydantoin compounds
US7186727B2 (en)	2004-12-14	2007-03-06	Bristol-Myers Squibb Company	Pyridyl-substituted spiro-hydantoin compounds and use thereof
EP2209371B1 (en)	2007-10-19	2017-01-04	SARcode Bioscience Inc.	Compositions and methods for treatment of diabetic retinopathy
CN102617533B (zh) *	2011-02-01	2014-08-27	北京北大维信生物科技有限公司	一种从红曲中分离的化合物、其制备方法及用途
EP3277274B1 (en)	2015-04-01	2024-06-12	Cedars-Sinai Medical Center	Anti-methanogenic lovastatin analogs or derivatives and uses thereof
KR102630720B1 (ko)	2015-08-28	2024-01-29	세키스이 메디칼 가부시키가이샤	벤질 화합물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4678806A (en)	1986-09-02	1987-07-07	Merck & Co., Inc.	Prodrugs of antihypercholesterolemic compounds
US4820850A (en)	1987-07-10	1989-04-11	Merck & Co., Inc.	Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof
US5021451A (en) *	1988-11-14	1991-06-04	Hoffman-La Roche Inc.	Method for inhibiting hyperproliferative diseases
DE69008277D1 (de) *	1989-08-31	1994-05-26	Merck & Co Inc	7-Subsituierte HMG-CoA-Reduktase-Inhibitoren.
NZ250609A (en) *	1992-12-28	1995-07-26	Sankyo Co	Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments
US5393893A (en) *	1993-11-08	1995-02-28	Apotex, Inc.	Process for producing simvastatin and analogs thereof
NZ512484A (en) *	1995-11-02	2003-02-28	Warner Lambert Co	Regulating lipid concentration in mammals by administering an acyl-CoA cholesterol O-acyltransferase (ACAT) inhibitor and an HMG-CoA reductase inhibitor
US5763653A (en) *	1997-03-13	1998-06-09	Ranbaxy Laboratories, Ltd.	Key intermediates in the manufacture of simvastatin
US5763646A (en) *	1997-03-13	1998-06-09	Ranbaxy Laboratories, Ltd.	Process for manufacturing simvastatin from lovastatin or mevinolinic acid
EP0971913B1 (en)	1997-01-28	2003-04-16	Plus Chemicals B.V.	Process for the production of semi synthetic statins via novel intermediates
EP1007033B1 (en) *	1997-08-28	2008-04-23	Novartis AG	Lymphocyte function antigen-1 antagonists

2000
- 2000-02-09 CO CO00008363A patent/CO5140104A1/es unknown
- 2000-02-14 ES ES00916832T patent/ES2226802T3/es not_active Expired - Lifetime
- 2000-02-14 DK DK00916832T patent/DK1154988T3/da active
- 2000-02-14 WO PCT/EP2000/001191 patent/WO2000048989A1/en active IP Right Grant
- 2000-02-14 BR BR0008292-9A patent/BR0008292A/pt not_active Application Discontinuation
- 2000-02-14 PE PE2000000114A patent/PE20001495A1/es not_active Application Discontinuation
- 2000-02-14 AR ARP000100626A patent/AR022588A1/es unknown
- 2000-02-14 PT PT00916832T patent/PT1154988E/pt unknown
- 2000-02-14 AT AT00916832T patent/ATE273272T1/de not_active IP Right Cessation
- 2000-02-14 SI SI200030511T patent/SI1154988T1/xx unknown
- 2000-02-14 CA CA002361841A patent/CA2361841C/en not_active Expired - Fee Related
- 2000-02-14 EP EP00916832A patent/EP1154988B1/en not_active Expired - Lifetime
- 2000-02-14 CN CNB008038171A patent/CN1229335C/zh not_active Expired - Fee Related
- 2000-02-14 DE DE60012888T patent/DE60012888T2/de not_active Expired - Fee Related
- 2000-02-14 AU AU38040/00A patent/AU763357B2/en not_active Ceased
- 2000-02-14 JP JP2000599730A patent/JP4167806B2/ja not_active Expired - Fee Related
2001
- 2001-08-13 US US09/928,593 patent/US20020037895A1/en not_active Abandoned
2002
- 2002-07-11 US US10/192,888 patent/US6818638B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
PT1154988E (pt)	2004-12-31
WO2000048989A1 (en)	2000-08-24
EP1154988A1 (en)	2001-11-21
DE60012888T2 (de)	2005-08-18
JP2002537284A (ja)	2002-11-05
US6818638B2 (en)	2004-11-16
AR022588A1 (es)	2002-09-04
JP4167806B2 (ja)	2008-10-22
CO5140104A1 (es)	2002-03-22
AU3804000A (en)	2000-09-04
CN1340044A (zh)	2002-03-13
CN1229335C (zh)	2005-11-30
CA2361841C (en)	2008-12-02
EP1154988B1 (en)	2004-08-11
ES2226802T3 (es)	2005-04-01
ATE273272T1 (de)	2004-08-15
DE60012888D1 (de)	2004-09-16
US20030087903A1 (en)	2003-05-08
PE20001495A1 (es)	2001-01-12
BR0008292A (pt)	2001-11-06
US20020037895A1 (en)	2002-03-28
SI1154988T1 (en)	2005-02-28
AU763357B2 (en)	2003-07-17
CA2361841A1 (en)	2000-08-24

Publication	Publication Date	Title
IS2116B (is)	2006-06-15	4-fenyl-pyridin afleiður
NO20021077D0 (no)	2002-03-05	Amino-triazolopyridin-derivater
ATE263748T1 (de)	2004-04-15	Admantan-derivate
DE50010060D1 (de)	2005-05-19	Thiazolylamid-derivate
IS6128A (is)	2001-10-26	13-Metýl-erýþrómýsín afleiður
DK1187814T3 (da)	2004-12-20	5-phenyl-pyrimidinderivater
DK1202953T3 (da)	2006-12-27	Substituerede 2-dialkylaminoalkylbiphenylderivater
NO20021803D0 (no)	2002-04-17	Isoksazolkarboksamid-derivater
PT1237857E (pt)	2004-10-29	Novos derivados fenalquiloxi-fenilo
ATE257148T1 (de)	2004-01-15	Propargyletherderivate
ATE273272T1 (de)	2004-08-15	Mevinolinderivate
ATE374747T1 (de)	2007-10-15	Monofluoralkylderivate
ATE254598T1 (de)	2003-12-15	4-hydroxybiphenylhydrazid-derivate
DK1187815T3 (da)	2006-06-19	4-phenyl-pyrimidinderivater
ATE293592T1 (de)	2005-05-15	Resorcinderivate
DE60025348D1 (de)	2006-03-30	Ethansulfonyl-piperidin-derivate
NO20020212D0 (no)	2002-01-15	3-amino-2-benzyl-1-fenyl-propanderivater
NO20022867D0 (no)	2002-06-14	Syklopentenon-derivater
TR200002831A3 (tr)	2001-04-20	Kinolin-4-Il türevleri I
PT1194401E (pt)	2004-02-27	Derivados de diacil-hidrazina
DK1178984T3 (da)	2003-06-10	1-trifluormethyl-4-hydroxy-7-piperidinylaminomethylchroman-derivater
ATE269328T1 (de)	2004-07-15	1-cycloalkylpyrazolyl-benzoyl-derivate